SCHEMBL3395575

SCHEMBL3395575

COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC1CN(C=CC=O)C1

nearest known ligand 0.72

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGFR P00533 9/20 0.72
ERBB2 P04626 13/20 0.68
EPHA2 P29317 4/20 0.62
EPHB4 P54760 4/20 0.62
GAK O14976 1/20 0.62
RIPK2 O43353 1/20 0.62
LYN P07948 1/20 0.62
RET P07949 1/20 0.62
EPHA1 P21709 1/20 0.62
ERBB3 P21860 1/20 0.62
EPHB2 P29323 1/20 0.62
EPHA5 P54756 1/20 0.62
EPHA4 P54764 1/20 0.62
ADK P55263 1/20 0.62
PTK6 Q13882 1/20 0.62
RIPK3 Q9Y572 1/20 0.62
KDR P35968 3/20 0.60
FLT1 P17948 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3394869 0.94 EGFR (0.75) EGFRERBB2EPHA2EPHB4GAK
SCHEMBL3391916 0.92 EGFR (0.77) EGFRERBB2EPHA2EPHB4GAK
SCHEMBL3391493 0.89 EGFR (0.72) EGFRERBB2EPHA2EPHB4RIPK2
SCHEMBL3394547 0.85 EGFR (0.71) EGFRERBB2EPHA2EPHB4KDR
SCHEMBL3390840 0.85 EGFR (0.72) EGFRERBB2EPHA2EPHB4RIPK2
SCHEMBL3433231 0.85 EGFR (0.65) EGFRERBB2EPHA2EPHB4GAK
SCHEMBL3390792 0.83 EGFR (0.64) EGFRERBB2EPHA2EPHB4GAK
SCHEMBL3395571 0.83 EGFR (1.00) EGFRERBB2EPHB4RIPK2RET
SCHEMBL3391766 0.83 EGFR (0.73) EGFRERBB2EPHB4RIPK2RET
SCHEMBL3127175 0.83 EGFR (0.92) EGFRERBB2EPHA2EPHB4GAK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2167492-A2 NOVEL AMIDE DERIVATIVE FOR INHIBITING THE GROWTH OF CANCER CELLS Hanmi Pharm. Co., Ltd. (KR) 2010-03-31 EP disclosed
WO-2008150118-A2 NOVEL AMIDE DERIVATIVE FOR INHIBITING THE GROWTH OF CANCER CELLS HANMI PHARM. CO., LTD. (KR) 2008-12-11 WO disclosed